This drug is not covered on the Reformulary.

There are other clinically similar drugs that are more cost-effective and coordinate well with provincial drug programs. Other therapies, available through Special Authorization, include biosimilars as well as other biologics or JAK inhibitors.

TREMFYA ONE-PRESS is used to treat  
Psoriasis
Psoriatic Arthritis